EA
XENT

Emerald Acquisition’s Intersect ENT, Inc XENT Stock Holding History

Emerald Acquisition’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$610K Sell
38,516
-4,213
-10% -$63.4K ﹤0.01% 2363
2016
Q2 		$552K Buy
+42,729
New +$669K ﹤0.01% 2429

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Emerald Acquisition's XENT Position: Q3 2016 in Review

Emerald Acquisition reduced its Intersect ENT, Inc (XENT) stake by 9.9% in Q3 2016, selling an estimated $63.4K and leaving 38,516 shares worth $610K. The position accounts for ﹤0.01% of the portfolio, ranked #2363.

Emerald Acquisition first reported a position in XENT in Q2 2016 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold XENT as of Q3 2016.

  • Emerald Acquisition held 38,516 shares of Intersect ENT, Inc worth $610K as of Q3 2016.
  • Emerald Acquisition sold 4,213 Intersect ENT, Inc shares in Q3 2016, an estimated $63.4K.
  • Intersect ENT, Inc made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2363 holding.
  • Emerald Acquisition first reported a position in Intersect ENT, Inc in Q2 2016 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.